Literature DB >> 7993941

Hemophilia A or von Willebrand disease?

J Batlle1, M J Blanco-Lopez, M Domenech, M Baiget, R Rocha, M F Lopez-Fernandez.   

Abstract

Seven members of the same family were studied on several occasions due to a history of hemorrhages. The propositus, a 12-year-old boy, his sister, one brother, and their father all had a low plasma factor VIII (FVIII) level. Von Willebrand factor (vWF) activity, vWF multimeric analysis, and vWF factor domain for binding to FVIII were normal in all seven subjects. The sister had a normal 46XX karyotype. The study of two intragenic restriction fragment length polymorphisms (RFLPs) and two closely linked, highly polymorphic extragenic markers showed a phenotypic expression of mild hemophilia A, which suggests that the sister of the propositus is homozygous or compound heterozygous at the hemophilia A locus. She would have inherited two hemophilic genes: one from her carrier mother and the other from her father, a mild hemophiliac.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7993941     DOI: 10.1007/BF01696562

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  9 in total

1.  A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction.

Authors:  C Mazurier; J Dieval; S Jorieux; J Delobel; M Goudemand
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  A new polymorphism in the factor VIII gene for prenatal diagnosis of hemophilia A.

Authors:  K L Wion; E G Tuddenham; R M Lawn
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

4.  An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. Application to hemophilia A.

Authors:  S C Kogan; M Doherty; J Gitschier
Journal:  N Engl J Med       Date:  1987-10-15       Impact factor: 91.245

Review 5.  Blood coagulation factor VIII (antihemophilic factor): with comments on von Willebrand's disease and Christmas disease.

Authors:  E M Barrow; J B Graham
Journal:  Physiol Rev       Date:  1974-01       Impact factor: 37.312

6.  Genetic screening for hemophilia A (classic hemophilia) with a polymorphic DNA probe.

Authors:  I Oberle; G Camerino; R Heilig; L Grunebaum; J P Cazenave; C Crapanzano; P M Mannucci; J L Mandel
Journal:  N Engl J Med       Date:  1985-03-14       Impact factor: 91.245

7.  Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII.

Authors:  M F López-Fernández; M J Blanco-López; M P Castiñeira; J Batlle
Journal:  Am J Hematol       Date:  1992-05       Impact factor: 10.047

8.  New variant of von Willebrand disease with defective binding to factor VIII.

Authors:  M Nishino; J P Girma; C Rothschild; E Fressinaud; D Meyer
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

9.  A clinically useful DNA probe closely linked to haemophilia A.

Authors:  K Harper; R M Winter; M E Pembrey; D Hartley; K E Davies; E G Tuddenham
Journal:  Lancet       Date:  1984-07-07       Impact factor: 79.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.